Delivery of biological agents by aerosols

AIChE Journal

Volumn 48, Issue 1, 2002, Pages 2-6

  Edwards, David A ^a,b  

^a HARVARD UNIVERSITY   (United States)

^b ALKERMES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; INSULIN;

AEROSOL; AREA UNDER THE CURVE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; HUMAN; LUNG ALVEOLUS EPITHELIUM; MEDICAL RESEARCH; METERED DOSE INHALER; REVIEW; SIDE EFFECT; UNITED STATES;

EID: 0010421564     PISSN: 00011541     EISSN: None     Source Type: Journal    
DOI: 10.1002/aic.690480102     Document Type: Review

References (35)

1. Adjei, A., "Guidelines for Development of Aerosolized Peptides," Inhalation Delivery of Therapeutic Peptides and Proteins, A. Adjei and P. Gupta, eds., Marcel Dekker, New York (2000).
2. Ansel, H., L. Allen, and N. Popovich, Pharmaceutical Dosage Forms and Drug Delivery Systems, Lippincott-Williams & Wilkins, Philadelphia, PA (1999).
3. Ben-Jebria, A., D. Chen, R. Vanbever, M. Eskew, and R. Langer, "Inhalation of Large Porous Albuterol Particles for Sustained Bronchodilation," Pharm. Res., 16, 555 (1999).
4. Bot, A., T. Tarara, D. Smith, S. Bot, C. Woods, and J. Weers, "Novel Lipid-Based Hollow-Porous Microparticles as a Platform for Immunoglobulin Delivery to the Respiratory Tract," Pharm. Res., 17, 275 (2000).
5. Brunner, G., B. Balent, M. Ellmerer, L. Schaupp, and A. Siebenhofer, "Dose-Response Relation of Liquid Aerosol Inhaled Insulin in Type I Diabetic Patients," Diabetologia, 44, 305 (2001).
6. Clark, A., "Medical Aerosol Inhalers: Past, Present and Future," Aerosol Sci. Technol., 22, 374 (1995).
7. Davies, C. N., Air Filtration, Academic Press, London (1973).
8. Dellamary, L., T. Tarara, D. Smith, C. Woelk, and A. Adractas, "Hollow Porous Particles in Metered Dose Inhalers," Pharm. Res, 17, 168 (2000).
9. DeYoung, L., "The Aerodose Multidose Inhaler - Device Design and Delivery Characteristics," RDD VI, R. Dalby, P. Byron, and S. Farr, eds., Interpharm Press, Buffalo Grove, IL, pp. 91-96 (1998).
10. Dunbar, C., "Respiratory Drug Delivery - Improving Quality of Life with Non-invasive Therapies," Eur. Pharm. Rev, 5, 48 (2000).
11. Dunbar, C., A. Hickey, and P. Holzner, "Dispersion and Characterization of Pharmaceutical Dry Powder Aerosols," KONA, 16, 7 (1998).
12. Edwards, D., J. Hanes, G. Caponetti, J. Hrkach, A. Ben-Jebria, J. Mintzes, and R. Langer, "Large Porous Particles for Pulmonary Drug Delivery," Science, 276, 1868 (1997).
13. Edwards, D., and C. Dunbar, "Therapeutic Aerosol Bioengineering," Ann. Rev. of Bioeng., in press (2002).
14. Farr, S., S. Warren, P. Lloyd, J. Okikawa, and J. Schuster, "Comparison of in vitro and in vivo Efficiencies of a Novel Unit-Dose Liquid Aerosol Generator and a Pressurized Metered Dose Inhaler," Int. J. Pharm., 198, 63 (2000).
15. Goodman, D., E. Israel, M. Rosenberg, R. Johnston, S. Weiss, and J. Drazen, "The Influence of Age, Diagnosis and Gender on Proper Use of Metered-Dose Inhalers," Am. J. Respir. Care Med., 150, 1250 (1994).
16. Heinemann, L., A. Pfutzner, and T. Heise, "Alternative Routes of Administration as an Approach to Improve Insulin Therapy: Update on Dermal, Oral, Nasal and Pulmonary Insulin Delivery," Current Pharm. Des., 7, 1327 (2001).
17. Heinemann, L., T. Traut, and T. Heise, "Time-Action Profile of Inhaled Insulin," Diabetic Med., 14, 63 (1997).
18. Heyder, J., J. Gebhart, G. Rudolf, C. Schiller, and W. Stahlhofen, "Deposition of Particles in the Human Respiratory Tract in the Size Range 0.005-15 μm," J. Aerosol Sci., 17, 811 (1986).
19. Heyder, J., and G. Rudolf, "Mathematical Models of Particle Deposition in the Human Respiratory Tract," J. Aerosol Sci., 15, 697 (1994).
20. Hinds, W. C., Aerosol Technology: Properties, Behavior and Measurement of Airborne Particles, Wiley, New York (1998).
21. Jenne, J., and S. Murphy, Drug Therapy for Asthma: Research and Clinical Practice, Marcel Dekker, New York (1987).
22. Masters, K., Spray Drying: An Introduction to Principles, Operational Practice, and Applications, Chemical Rubber Co., Cleveland, OH (1985).
23. NRC Committee Report, "Chemical and Biological Terrorism. Research Development to Improve Civilian Medical Response," National Academy Press, Washington, DC (1999).
24. Osborn, C., R. Batycky, A. Verma, A. Illerperuma, and C. Tusek, "Time-Action Profile of a New Rapid Acting Inhaled Insulin with High Biopotency," 61st Scientific Sessions, ADA, Philadelphia (2001).
25. Scheuch, F., T. Meyer, K. Sommerer, H. Lichte, and A. Pohner, "Measuring in vivo Deposition of Large Porous Particles," J. Aerosol Med., 12, 138 (1999).
26. Schuster, J., R. Rubasmen, P. Lloyd, and J. Lloyd, "Generation of Medicinal Aerosols for Systemic Effect: the AerX System," Pharm. Res., 14, 354 (1997).
27. Skyler, J., W. Cefalu, I. Kourides, W. Landschulz, and C. Balagtas, "Efficacy of Inhaled Human Insulin in Type 1 Diabetes Mellitus: A Randomised Proof-of-Concept Study," The Lancet, 357, 331 (2001).
28. Strauss, W., Industrial Gas Cleaning, Pergammon Press, New York (1975).
29. Thiel, C., "From Susie's Question to CFC Free: An inventor's Perspective on Forty Years of MDI Development," RDD V, P. Byron, R. N. Dalby, and S. J. Farr, eds., Interpharm Press, Buffalo Grove, IL, p. 115 (1996).
30. Tong, H., B. Shekunov, P. York, and A. Chow, "Characterization of Two Polymorphs of Salmeterol Xinafoate Crystallized from Supercritical Fluids," Pharm. Res., 18, 852 (2001).
31. Walton, W. H., and B. McGovern, Proceedings of an International Symposium Organized by the British Occupational Hygiene Society, Pergamon Press, New York, p. 3 (1977).
32. Weibel, E., "Morphological Basis of Alveolar-Capillary Gas Exchange," Physiol. Rev., 53, 419 (1973).
33. Weibel, E. R., Morphometry of the Human Lung, Springer-Verlag, Berlin (1963).
34. Weinberger, M., "Safety of Oral Corticosteroids," Eur. J. Resp. Dis., 63, 243 (1982).
35. Williams, S., and A. Seaton, "Intravenous or Inhaled Salbutamol in Severe Acute Asthma," Thorax, 32, 555 (1977).